Aggregation: the impurity your chromatogram dissolved before it looked
We describe each pathway in enough chemical detail to explain why it is invisible to the method the trade uses, because that is the part which has practical consequences.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 4 of 51 of this archive, newest first.
We describe each pathway in enough chemical detail to explain why it is invisible to the method the trade uses, because that is the part which has practical consequences.
Reported from the analysis, not from a warning notice.
Reported from the analysis, not from a warning notice.
Accreditation to the international competence standard covers the scope a laboratory has been assessed for, which is not necessarily the test you commissioned.
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
At low concentrations a measurable fraction of peptide can adsorb to glass and plastic surfaces, and the loss is largest exactly where it is least expected.
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
A reminder that a purity figure is the output of a method, and that methods differ.
We asked all four services what they can determine, on what timescale, at what price, and under what accreditation. The answers are printed in full.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The Journal has read several hundred certificates from twenty companies. We set out what the documents actually cover, and what a reader is filling in from imagination.
The absence of microbiological capability in this market is a commercial fact with a straightforward explanation, and it is worth understanding before blaming anybody for it.
The result is unremarkable. What the report states alongside it is not.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Nothing on this page is difficult. It is simply unfamiliar, and unfamiliarity is what makes a weak certificate look like a strong one.